The Cbl family of signal transduction molecules

Critical Reviews in Oncogenesis

Volumn 8, Issue 4, 1997, Pages 359-379

  Smit, Linda ^a   Borst, Jannie ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Negative regulation; Oncogenesis; Protein tyrosine kinase; Receptor; Scaffold protein

Indexed keywords

ADAPTOR PROTEIN; MUTANT PROTEIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; CARCINOGENESIS; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; MOLECULAR CLONING; NONHUMAN; ONCOGENE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SECOND MESSENGER; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0031394111     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevoncog.v8.i4.50     Document Type: Review

References (109)

1. Andoniou, C. E., C. B. F Thien, and W. Y. Langdon: Tumor induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J., 13:4515-4523 (1994).
2. Andoniou, C. E., C. B. F. Thien, and W. Y. Langdon: The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain. Oncogene, 12:1981-1989 (1996).
3. Aroian, R. V., M. Koga, J. E. Mendel, Y. Ohshima, and P. W. Sternberg: The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature, 348:693-699 (1990).
4. Barber, D. L., D. W. Mason, T. Fukazawa, K. Reedquist, B. Druker, H. Band, and A. D. D' Andrea: Erythropoietin and interleukin-3 activate tyrosine phosphorylation of Cbl and association with Crk adaptor proteins. Blood, 89:3166-3174 (1997).
5. Blake, T. J. and W. Y. Langdon: The sequences of the human and mouse c-Cbl protooncogenes show v-Cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene, 6:653-657 (1991).
6. Blake, T. J. and W. Y. Langdon: A rearrangement of the c-cbl protooncogene in HUT78 T-lymphoma cells results in a truncated protein. Oncogene, 7:757-762 (1992).
7. Blake, T., K. Heath, and W. Langdon: The truncation that generated the v-Cbl oncogene reveals an ability for nuclear transport, DNA binding and acute transformation. EMBO J., 12:2017-2026 (1993).
8. Bonita, D. P., S. Miyake, M. L. Lupher, W. Y. Langdon, and H. Band: Phosphotyrosine binding domain-dependent upregulation of the platelet-derived growth factor receptor a signaling cascade by transforming mutants of Cbl: implications for Cbl's function and oncogenicity. Mol. Cell. Biol., 17:4597-4610 (1997).
9. Boussiotis, V. A., G. J. Freeman, A. Berezovskaya, D. L. Barber, and L. M. Nadler: Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap-1. Science, 278:124-128 (1997).
10. Bowtell, D. D. L. and W. Y. Langdon: The protein product of the c-Cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation. Oncogene, 11:1561-1567 (1995).
11. Buday, L. and J. Downward: Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell, 73:611-620 (1993).
12. Buday, L., P. H. Warne, and J. Downward: Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos. Oncogene, 11:1327-1331 (1995).
13. Buday, L., A. Khwaja, S. Sipeki, A. Farago, and J. Downward: Interactions of Cbl with two adaptor proteins, Grb2 and Crk, upon T cell activation. J. Biol. Chem., 271:6159-6163 (1996).
14. Bustelo, X. R., P. Crespo, M. Lopez-Barahona, J. S. Gutkind, and M. Barbacid: Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene, 15:2511-2520 (1997).
15. Chardin, P., J. H. Camonis, N. W. Gale, L. Van Aelst, J. Schlessinger, M. H. Wigler, and D. Bar-Sagi: Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science, 260:1338-1343 (1993).
16. Clark, S. G., M. J. Stern, and H. R. Horvitz: C. elegans cell signaling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature, 356:340-344 (1990).
17. Chelsky, D., R. Ralph, and G. Jonak: Sequence requirements for synthetic peptide-mediated translocation to the nucleus. Mol. Cell. Biol., 9:2487-2492 (1989).
18. Cherniak, A. D., J. K. Klarlund, B. R. Conway, and M. P. Czech: Disassembly of son-of-sevenless proteins from Grb2 during p21ras desensitization by insulin. J. Biol. Chem., 270:1485-1488 (1995).
19. Cook, S. J., B. Rubinfield, I. Albert, and F. McCormick: RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J., 12:3475-3485 (1993).
20. Cory, G. O., R. C. Lovering, S.; Hinshelwood, L. MacCarthy-Morrogh, R. J. Levinsky, and C. Kinnon: The protein product of the c-Cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase. J. Exp. Med., 182:611-615(1995).
21. Crespo, P., X. R. Bustelo, D. S. Aaronson, O. A. Coso, M. Lopez-Barahona, M. Barbacid, and J. S. Gutkind: Rac-I dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene, 13:455-460 (1996).
22. Crespo, P., K. E. Schuebel, A. A. Omstron, J. S. Gutkind, and X. R. Bustelo: Phosphotyrosine dependent activation of Rac-1 GDP/GTP exchange by the vav protooncogene product. Nature, 385:569-572 (1997).
23. DeFranco, A. L.: Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr. Opin. Cell. Biol., 7:163-175 (1995).
24. Donovan, J. A., R. L. Wange, W. Y. Langdon, and L. E. Samelson: The protein product of the c-Cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkat T cells activated via the T cell antigen receptor. J. Biol. Chem., 269:22921-22924 (1994).
25. Donovan, J. A., Y. Ota, W. Y. Langdon, and L. E. Samelson: Regulation of the association of p120cbl with Grb2 in Jurkat cells. J. Biol. Chem., 271:26369-26374 (1996).
26. c-cbl in T lymphocytes. J. Exp. Med., 183:301-306 (1996).
27. Frederickson, T. N., W. Y. Langdon, P. M. Hoffman, J. W. Hartley, and H. C. Morse III: Histologic and cell surface antigen studies of hemotopoietic tumors induced by Cas-Br-M murine leukemia virus. J. Natl. Cancer Inst., 72:447-452 (1984).
28. Fukazawa, T., K. A. Reedquist, T. Trub, S. Soltoff, G. Panchamoorthy, B. Druker, L. Cantley, S. E. Shoelson and H. Band: The SH3 domain-binding T cell tyrosyl phosphoprotein p 120. Demonstration of its identity with the c-Cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem., 270:19141-19150 (1995).
29. Fukazawa, T., S. Miyake, V. Band, and H. Band: Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) Stimulation and its association with EOF receptor and downstream signaling proteins. J. Biol. Chem., 271:14554-14559 (1996).
30. Galisteo, M. L., I. Dikic, A. G. Batzer, W. Y. Langdon, and J. Schlessinger: Tyrosine phosphorylation of the c-Cbl protooncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation. J. Biol. Chem., 270:20242-20245 (1995).
31. van der Geer, P., S. Wiley, V. Ka-Man Lai, J. P. Olivier, G. D. Gish, R. Stephens, D. Kaplan, S. Shoelson, and T. Pawson: A conserved amino-terminal Shc domain binds to phophotyrosine motifs in activated receptors and phosphopeptides. Curr. Biol., 5:404-412 (1995).
32. Gotoh, T., S. Hattori, S. Nakamura, H. Kitayama, M. Noda, Y. Takai, K. Kaibuchi, H. Matsui, O. Hatase, H. Takahashi, T. Kurata, and M. Matsuda: Identification of Rap l as a target for the Crk SH3 domain binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol., 15:6746-6753 (1995).
33. Han, M. and P. W. Sternberg: let-60, a gene that specifies cell fates during C. elegans vulval induction, encodes a ras protein. Cell, 63:921-931 (1990).
34. Hariharen, I. K., R. W. Carthew, and G. M. Rubin: The Drosophila roughened mutation: activation of a rap homolog disrupts eye development and interferes with cell determination. Cell, 67:717-722 (1991).
35. Hartley J. W. and W. P. Row: Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J. Virol., 19:19-25 (1976).
36. Hartley, J. W., N. K. Wolford, L. J. Old, and W. P. Rowe: A new class of murine leukemia virus associated with development of spontaneous lymphomas. Proc. Natl. Acad. Sci. U.S.A., 74:789-792 (1977).
37. Hartley, D., H. Meisner, and S. Corvera: Specific association of the β isoform of the p85 subunit of phosphatidylinositol-3 kinase with the protooncogene c-Cbl. J. Biol. Chem., 270:18260-18263 (1995).
38. Hata, Y., A. Kikuchi, T. Sasaki, M. D. Schaber, J. B. Gibbs, and Y. Takai: Inhibition of the ras p21 GTPase-activating protein-stimulated GTPase activity of c-Ha-ras p21 by smg p21 having the same putative effector domain as ras p21s. J. Biol. Chem., 265:7104-7107(1990).
39. Herman, P. K. and S. D. Emr: Characterization of VPS34, a gene required for vacuolar protein sorting and vacuole segragation in Saccharomyces cerevisiae. Mol. Cell. Biol., 10:6742-6754 (1990).
40. Hime, G. R., M. P. Dhungat, A. Ng, and D. D. L. Bowtell: D-Cbl, the Drosophila homologue of the c-Cbl protooncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites. Oncogene, 14:2709-2719 (1997).
41. ten Hoeve, J., C. Morris, N. Heisterkamp, and J. Groffen: Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene, 8:2469-2474 (1993).
42. Holmes, K. L., W. Y. Langdon, T. N. Frederickson, R. L. Coffman, P. M. Hoffman, J. W. Hartley, and H. C. Morse, III: Analysis of neoplasms induced by Cas-Br-M MulV tumor extracts. J. Immunol., 137:679-688 (1986).
43. Joly, M., A. Kazlauskas, F. S. Fay, and S. Corvera: Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science, 263:684-687 (1994).
44. de Jong, R., J. ten Hoeve, N. Heisterkamp, and J. Kuffen: CrkI is complexed with tyrosine phosphorylated Cbl in Ph-positive leukemia: J. Biol. Chem., 270:21468-21471 (1995).
45. Jongeward, G. D., T. R. Clandinin, and P. W. Sternberg: Sli-1, a negative regulator of let-23 mediated signaling in C. elegans. Genetics, 139:1553-1566 (1995).
46. Jones, C., L. Penny, T. Mattina, S. Yu, E. Baker, L. Voullaire, W. Y. Langdon, G. R. Sutherland, R. I. Richards, and A. Tunnacliffe: Association of a chromosome deletion syndrome with a fragile site within the protooncogene CBL2. Nature, 376:145-149 (1995).
47. Keane, M. M., O. M. Rivero-Lezcano, J. A. Mitchell, K. C. Robbins, and S. Lipkowitz: Cloning and characterication of cbl-b: a SH3 binding protein with homology to the c-Cbl protooncogene. Oncogene, 10:2367-2377 (1995).
48. Khwaja, A., B. Hallberg, P. H. Warne, and J. Downward: Networks of interaction of p120cbl and p130cas with Crk and Grb2 adaptor proteins. Oncogene, 12:2491-2498 (1996).
49. Kim, T. J., Y.-T. Kim, and S. Pillai: Association of activated phosphatidylinositol 3-kinase with p120Cbl in antigen receptor-ligated B cells. J. Biol. Chem., 270:27504-27509 (1995).
50. Kitayama, H., Y. Sugimoto, T. Matsuzaki, Y. Ikawa, and M. Noda: A ras-related gene with transformation suppressor activity. Cell, 56:77-84 (1989).
51. Kitayama, H., T. Matsuzaki, Y. Ikawa, and M. Noda: Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations. Proc. Natl. Acad. Sci. U.S.A., 87:4284-4288 (1990).
52. Kontani, K., I. Kukimoto, H. Nishina, S. Hoshino, O. Hazeki, Y. Kanaho, and T. Katada: Tyrosine phosphorylation of the c-Cbl protooncogene product mediated by cell surface antigen CD38 in HL-60 cells. J. Biol. Chem., 271:1534-1537 (1996).
53. Landschutz, W. H., P. F. Johnson, and S. L. McKnight: The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science, 240:1759-1764 (1988).
54. Langdon, W. Y., J. W. Hartley, K. L. Holmes, T. N. Fredrickson, and H. C. Morse, III: Identification of a transforming virus from a lymphoma of a mouse infected with a wild mouse retrovirus. Curr. Top. Microbiol. Immunol., 113:241-249 (1984).
55. Langdon, W. Y., C. H. Hyland, R. J. Grumont, and H. C. Morse, III: The c-cbl protooncogene is preferentially expressed in thymus and testis tissue and encodes a nuclear protein. J. Virol, 63:5420-5424 (1989a).
56. Langdon, W. Y., J. W. Hartley, S. P. Klinken, S. K. Ruscetti, and H. C. Morse, III: v-Cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc. Natl. Acad. Sci. USA, 86:1168-1172 (1989b).
57. Lee, J., G. D. Jongeward, and P. W. Sternberg: unc-101, a gene required for many aspects of Caenorhabditis elegans development and behavior, encodes a clathrin-associated protein. Genes Dev., 8:60-73 (1994).
58. Levkowitz, G., L. N. Klapper, E. Tzahar, A. Freywald, M. Sela, and Y. Yarden: Coupling of the c-Cbl protooncogene product to ErbB-1 /EGF-receptor but not to other ErbB proteins. Oncogene, 12:1117-1125 (1996).
59. Liu, Y.-C., C. Elly, H. Yoshida, N. Bonnefoy-Berard, and A. Altman: Activation-modulated association of 14-3-3 proteins with Cbl in T cells. J. Biol. Chem., 271:14591-14595 (1996).
60. 2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J. Biol. Chem., 272:168-173 (1997).
61. Lovering, R., I. M. Hanson, K. L. B. Borden, S. Martin, N. J. O'Reilly, G. I. Evan, D. Rahman, D. J. C. Pappin, J. Trowsdale, and P. S. Freemont: Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl. Acad. Sci. U.S.A., 90:2112-2116 (1993).
62. Lupher, M. L., Jr., K. A. Reedquist, S. Miyake, W. Y. Langdon, and H. Band: A novel phosphotyrosinebinding domain in the N-terminal transforming region of Cbl interacts directly and selectively with Zap-70 in T cells. J. Biol. Chem. 271:24063-24068 (1996).
63. Lupher, M. L., Z. Songyang, S. E. Shoelson, L. C. Cantley, and H. Band: The Cbl phosphotyrosine binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatoy tyrosine phosphorylation site of ZAP-70. J. Biol. Chem. 272:33140-33144 (1997).
64. Marcilla, A., O. M. Rivero-Lezcano, A. Agarwal, and K. C. Robbins: Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Feγ receptors. J. Biol. Chem. 270:9115-9120 (1995).
65. Marengere, L. E. M., C. Mirtsos, I. Kozieradzki, A. Veillette, T. W. Mak, and J. M. Penninger: Protooncoprotein Vav interacts with c-Cbl in activated thymocytes and pheripheral T cells. J. Immunol., 159:70-76 (1997).
66. Matsuda, M., Y. Hashimoto, K. Muroya, H. Hasegawa, T. Kurata, S. Tanaka, S. Nakamura, and S. Hattori: CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol. Cell. Biol., 14:5495-5500 (1994).
67. Meisner, H. and M. P. Czech: Coupling of the protooncogene product c-Cbl to the epidermal growth factor receptor. J. Biol. Chem., 270:25332-25335 (1995).
68. Meisner, H., B. R. Conway, D. Hartley, and M. P. Czech: Interaction of Cbl with Grb2 and phosphatidylinositol 3′-kinase in activated Jurkat T cells. Mol. Cell. Biol., 15:3571-3578 (1995).
69. Meisner, H., A. Daga, J. Buxton, B. Fernandez, A. Chawla, U. Banerjee, and M. Czech: Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol., 17:2217-2225 (1997).
70. Mushinski, J. F., J. Goodnight, E. Rudikoff, H. C. Morse, III, and W. Y. Langdon: Expression of the c-cbl protooncogene is modulated during differentiation but not during induction of proliferation. Oncogene, 9:2489-2497 (1994).
71. Odai, H., K. Sasaki, A. Iwamatsu, Y. Hanazono, T. Tanaka, K. Mitanai, Y. Yazaki, and H. Hirai: The protooncogene product c-cbl becomes tyrosine phosphorylated by stimulation with GM-CSF or Epo and constitutively binds to the SH3 domain of Grb2/Ash in human hematopoietic cells. J. Biol. Chem., 270:10800-10805 (1995).
72. Ojaniemi, M., S. S. Martini, F. Dolfi, J. M. Olefsky, and K. Vuori: The protooncogene product p 120cbl links c-Src and phosphatidylinositol 3′-kinase to the integrin signaling pathway. J. Biol. Chem., 272:3780-3787 (1997).
73. Ota, Y., L. O. Beitz, A. M. Scharenberg, J. A. Donovan, J.-P. Kinet, and L. E. Samelson: Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J. Exp. Med., 184:1713-1723 (1996).
74. Ota, Y. and L.E. Samelson: The product of the protooncogene c-Cbl: a negative regulator of the Syk tyrosine kinase. Science, 276:418-420 (1997).
75. Panchamoorthy, G., T. Fukazawa, S. Miyake, S. Soltoff, K. Reedquist, B. Druker, S. Shoelson, L. Cantley, and H. Band: p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and Shc adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem., 271:3187-3194 (1996).
76. Reedquist, K. A., T. Fukazawa, B. Druker, G. Panchamoorthy, S. E. Shoelson, and H. Band: Rapid T-cell receptor mediated tyrosine phosphorylation of p 120, an Fyn/ Lck Src homology 3 domain-binding protein. Proc. Natl. Acad. Sci. U.S.A., 91:4135-4139 (1994).
77. Reedquist, K. A., T. Fukazawa, G. Panchamoorthy, W. Y. Langdon, S. E, Shoelson, B. J. Druker, and H. Band: Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J. Biol. Chem., 271:8435-8442 (1996).
78. Regnier, D. C., C. A. Kozak, D. M. Kingsley, N. A. Jenkins, N. G. Copeland, W. Y. Langdon, and H. C. Morse, III: Identification of two murine loci homologous to the v-cbl oncogene. J. Virol., 63:3678-3682 (1989).
79. Rellahan, B. L., L. J. Graham, B. Stoica, K. E. DeBeil, and E. Bonvini: Cbl-mediated regulation of T cell receptor-induced AP1 activation. Implications for activation via the Ras signaling pathway. J. Biol. Chem., 272:30806-30811 (1997).
80. Ribon, V., S. Hubbell, R. Herrera, and A. R. Saltiel: The product of the cbl oncogene forms stable complexes in vivo with endogenous Crk in a tyrosine phosphorylation-dependent manner. Mol. Cell. Biol., 16:45-52 (1996).
81. Rivero-Lezcano, O. M., J. H. Sameshima, A. Marcilla, and K. C. Robbins: Physical association between Src homology 3 elements and the protein product of the c-cbl protooncogene. J. Biol. Chem., 269:17363-17366 (1994).
82. Robertson, H., W. Y. Langdon, C. B. F. Thien, and D. D. L. Bowtell: A c-Cbl yeast two-hybrid screen reveals interactions with 14-3-3 isoforms and cytoskeletal components. Biochem. Biophys. Res. Commun., 240:46-50 (1997).
83. Roche, S., M. Koegl, M. V. Barone, M. F. Roussel and S. A. Courtneidge: DNA synthesis induced by some but not all growth factors requires Src family tyrosine kinases. Mol. Cell. Biol., 15:1102-1109 (1995).
84. Sasaki, K., H. Odai, Y. Hanazono, H. Ueno, S. Ogawa, W. Y. Langdon, T. Tanaka, K. Miyagawa, K. Mitani, Y. Yazaki, and H. Hirai: TPO/c-mpl ligand induces tyrosine phosphorylation of multiple cellular proteins including protooncogene products, Vav and c-Cbl, and Ras signaling molecules. Biochem. Biophys. Res. Commun., 216:338-347 (1995).
85. Sattler, M., R. Salgia, K. Okuda, N. Uemura, M. A. Durstin, E. Pisick, G. Xu, J-L. Li, K. V. Prasad, and J. D. Griffin: The protooncogene product p120cbl and the adaptor proteins CrkL and c-Crk link C-Abl, p 190bcr-abl and p210bcr/abl to the phosphatidylinositol-3′ kinase pathway. Oncogene, 12:839-846 (1996).
86. Savage, P. D., M. Shapiro, W. Y. Langdon, A. D. Geurts van Kessel, H. N. Seuanez, Y. Akao, C. Croce, H. C. Morse, III, and J. H. Kersey: Relationship of the human protooncogene CBL2 on 11 q23 to the t(4; 11 ), t(11;22), and t(11;14) breakpoints. Cytogenet. Cell. Genet., 56:112-115 (1991).
87. Sawasdikosol, S., J.-H. Chang, J. C. Pratt, G. Wolf, S. E. Shoelson, and S. Burakoff: Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. J. Immunol., 157:110-116 (1996).
88. Schuebel, K. E., X. R. Bustelo, D. A. Nielsen, B. J. Song, M. Barbacid, D. Goldman, and I. J. Lee: Isolation and characterization of murine vav2, a member of the vav family of protooncogenes. Oncogene, 13:363-371 (1996).
89. Smit, L., A. M. M. de Vries-Smits, J. L. Bos, and J. Borst: B cell antigen receptor stimulation induces formation of a Shc-Grb2 complex containing multiple tyrosine-phosphorylated proteins. J. Biol. Chem., 269:20209-20212 (1994).
90. Smit, L., G. van der Horst, and J. Borst: Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J. Biol. Chem., 271:8564-8569 (1996a).
91. Smit, L., G. van der Horst, and J. Borst: Formation of Shc/ Grb2 and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. Oncogene, 12:381-389 (1996b).
92. Soltoff, S. P. and L. C. Cantley: P120cbl is a cytosolic adapter protein that associates with phosphoinositide 3-kinase in response to epidermal growth factor in PC 12 and other cells. J. Biol. Chem. 271:563-577 (1996).
93. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffausen, and L. C. Cantley: SH2 domains recognize specific phosphopeptide sequences. Cell, 72:767-778 (1993).
94. Tanaka, S., T. Morishita, Y. Hashimoto, S. Hattori, S. Nakamura, M. Shibuya, K. Matuoka, T. Takenawa, T. Kurata, K. Nagashima, and M. Matsuda: C3G, a guanine nucleotide-releasing protein expressed ubiqui- tously, binds to the Src homology 3 domains of Crk and Grb2/Ash proteins. Proc. Natl. Acad. Sci. U.S.A., 91:3443-3447 (1994).
95. Tanaka, S., L. Neff, R. Baron, and J. B. Levy: Tyrosine phosphorylation and translocation of the c-Cbl protein after activation of tyrosine kinase signaling pathways. J. Biol. Chem., 270:14347-14351 (1995).
96. Tezuka, T., H. Umemori, N. Fusaki, T. Yagi, M. Takata, T. Kurosaki, and T. Yamamoto: Physical and functional association of the Cbl protooncogene product with an Src-family protein tyrosine kinase, p53/561yn, in the B cell antigen receptor-mediated signaling. J. Exp. Med., 183:675-680 (1996).
97. Thien, C. B. F. and W. Y. Langdon: EOF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans Sli-1 gene. Oncogene, 14:2239-2249 (1997a).
98. Thien, C. B. F. and W. Y. Langdon: Tyrosine kinase activity of the EGF receptor is enhanced by the expression of oncogenic 70Z-Cbl. Oncogene, 15:2909-2919 (1997b).
99. Tsygankov, A. Y., S. Mahajan, J. E. Fincke, and J. B. Bolen: Specific association of tyrosine phosphorylated c-Cbl with Fyn tyrosine kinase in T cells. J. Biol. Chem., 271:27130-27137 (1996).
100. Tunnacliffe, A. and R. S. McGuire: A physical linkage group in human chromosome band 1 1q23 covering a region implicated in leukocyte neoplasia. Genomics, 8:447-453 (1990).
101. Uddin, S., C. Cardziola, A. Dangat, T. Yi, and L. C. Platanias: Interaction of the c-cbl protooncogene product with the Tyk-2 protein tyrosine kinase. Biochem. Biophys. Res. Comm., 225:833-838 (1996).
102. Ueno, H., K. Sasaki, K. Miyagawa, H. Honda, K. Mitani, Y. Yazaki, and H. Hirai: Antisense repression of protooncogene c-Cbl enhances activation of the Jak-Stat pathway but not the Ras pathway in epidermal growth factor receptor signaling. J. Biol. Chem., 272:8739-8743 (1997).
103. Wang, Y., Y. G. Yeung, W. Y. Langdon, and E. R. Stanley: c-Cbl is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 Stimulation of macrophages. J. Biol. Chem., 271:17-20 (1996).
104. Waters, S. B., K. Yamauchi, and J. E. Pessin: Insulin-stimulated disassociation of the SOS-Grb2 complex. Mol. Cell. Biol., 15:2791-2799 (1995).
105. de Weers, M., G. S. Brouns, S. Hinshelwood, C. Kinnon, R. K. B. Schuurman, R. W. Hendriks, and J. Borst: B cell antigen receptor stimulation activates the human Bruton's tyrosine kinase, which is deficient in X-linked Agammaglobulinemia. J. Biol. Chem., 269:23857-23860 (1996).
106. Weiss, A. and D. R. Littman: Signal transduction by lymphocyte antigen receptors. Cell, 76:263-274 (1994).
107. Wisniewski, D., A. Strife, and B. Clarkson: c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. Leukemia, 10:1436-1442 (1996).
108. Wolf, G., T. Trub, E. Ottinger, L. Groninga, A. Lynch, M. F. White, M. Miyazaki, J. Lee, and S. E. Shoelson: PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J. Biol. Chem., 270:27407-27410 (1995).
109. Yoon, C. H., J. Lee, G. D. Jongeward, and P. W. Sternberg: Similarity of sli-1, a regulator of vulval development in C. elegans to the mammalian protooncogene c-Cbl. Science, 269:1102-1105 (1995).